Description of study flow
adenomyosis, uterine fibroids, uterine synechiae
ADENOMYOSIS, UTERINE FIBROIDS, MVP
176 women were screened for this study between March 2019 and September 2019. Fourteen women did not meet the inclusion criteria: adenomyosis (n=2), multiple uterine fibroids (n=5), and severe uterine synechiae (n=7). Therefore, 162 women were randomized and participated in the trial, of which 81 women were allocated to the oral dydrogesterone (DYD) group and 81 women to the micronized vaginal progesterone (MVP) group (Flow chart of the study participants who underwent fresh embryo transfer.